$0.900100
~00.01%
Pre-Market: Sep 23, 6:26 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Oncolytics Biotech in recent months.
Browse guidance and forecast on all stocks.